Real-World study tracks Trazodone's effect on depression and memory in seniors
NCT ID NCT07377682
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is observing how the medication trazodone helps older adults (55+) who have both major depression and mild memory or thinking problems. Researchers will track changes in depression symptoms and thinking skills during routine care in Italy, Poland, and Romania. The goal is to understand how well trazodone works in everyday medical practice, not to test a new drug.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITION DISORDERS IN OLD AGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Poradnia Medycyna Miłorząb: pl. Pokoju 3/4, 90-227 Łódź. Poland
RECRUITINGLodz, Poland, 93-005, Poland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we predict who returns to work after stress treatment?
- Can a Parent-Targeted program ease Kids' behavior problems when depression is in the picture?
- A Two-Year watch: can brain scans and surveys predict depression and anxiety in teens?
- Can a Three-Session therapy rival CBT for Event-Related depression?
- Your genes could hold the key to better depression treatment
- A therapy that aims to boost wellbeing, not just ease symptoms — a trial puts it to the test